{"entity":{"type":"insider","cik":"0001340881","url":"/insider/0001340881","json_url":"/insider/0001340881.json","name":"Drapkin Kimberlee C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2018-03-07","last":"2023-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Drapkin Kimberlee C","source":"filing","n_filings":10,"first_seen":"2018-03-07","last_seen":"2023-01-11"}],"transactions":[{"id":8181491,"accession":"0001640455-23-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-23-000009","line_url":"/filing/0001640455-23-000009#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7781.0,"shares_display":"7,781","price_per_share":1.12,"price_display":"1.12","price_state":"stated","total_value":8714.72,"total_display":"8,714.72","total_whole":"8,715","shares_owned_after":66018.0,"shares_owned_after_display":"66,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":8181490,"accession":"0001640455-23-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-23-000009","line_url":"/filing/0001640455-23-000009#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6315.0,"shares_display":"6,315","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":6946.5,"total_display":"6,946.50","total_whole":"6,947","shares_owned_after":73799.0,"shares_owned_after_display":"73,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6402045,"accession":"0001640455-22-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-22-000009","line_url":"/filing/0001640455-22-000009#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8222.0,"shares_display":"8,222","price_per_share":6.65,"price_display":"6.65","price_state":"stated","total_value":54676.3,"total_display":"54,676.30","total_whole":"54,676","shares_owned_after":52614.0,"shares_owned_after_display":"52,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider"},{"id":6402044,"accession":"0001640455-22-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-22-000009","line_url":"/filing/0001640455-22-000009#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4595.0,"shares_display":"4,595","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":33543.5,"total_display":"33,543.50","total_whole":"33,544","shares_owned_after":60836.0,"shares_owned_after_display":"60,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":4334602,"accession":"0001640455-21-000016","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001640455-21-000016","line_url":"/filing/0001640455-21-000016#line-7","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3799.0,"shares_display":"3,799","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":45588.0,"total_display":"45,588.00","total_whole":"45,588","shares_owned_after":43181.0,"shares_owned_after_display":"43,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-22","scope":"insider"},{"id":4334591,"accession":"0001640455-21-000016","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001640455-21-000016","line_url":"/filing/0001640455-21-000016","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26201.0,"shares_display":"26,201","price_per_share":11.266670356093279,"price_display":"11.27","price_state":"stated","total_value":295198.03,"total_display":"295,198.03","total_whole":"295,198","shares_owned_after":53181.0,"shares_owned_after_display":"53,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider","n_lines":2},{"id":4647053,"accession":"0001640455-21-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-21-000008","line_url":"/filing/0001640455-21-000008#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3130.0,"shares_display":"3,130","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":21910.0,"total_display":"21,910.00","total_whole":"21,910","shares_owned_after":55881.0,"shares_owned_after_display":"55,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-11","scope":"insider"},{"id":4647047,"accession":"0001640455-21-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-21-000008","line_url":"/filing/0001640455-21-000008#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2697.0,"shares_display":"2,697","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":18231.72,"total_display":"18,231.72","total_whole":"18,232","shares_owned_after":59011.0,"shares_owned_after_display":"59,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-11","scope":"insider"},{"id":2594506,"accession":"0001640455-20-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000114","line_url":"/filing/0001640455-20-000114#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":58032.0,"total_display":"58,032.00","total_whole":"58,032","shares_owned_after":61708.0,"shares_owned_after_display":"61,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-02","scope":"insider"},{"id":2766127,"accession":"0001640455-20-000109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001640455-20-000109","line_url":"/filing/0001640455-20-000109#line-3","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":744.0,"shares_display":"744","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":3504.24,"total_display":"3,504.24","total_whole":"3,504","shares_owned_after":68908.0,"shares_owned_after_display":"68,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider"},{"id":2766123,"accession":"0001640455-20-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-20-000109","line_url":"/filing/0001640455-20-000109#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":454.0,"shares_display":"454","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":2206.44,"total_display":"2,206.44","total_whole":"2,206","shares_owned_after":69652.0,"shares_owned_after_display":"69,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2766119,"accession":"0001640455-20-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000109","line_url":"/filing/0001640455-20-000109#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":984.0,"shares_display":"984","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":4565.76,"total_display":"4,565.76","total_whole":"4,566","shares_owned_after":70106.0,"shares_owned_after_display":"70,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-18","scope":"insider"},{"id":2320837,"accession":"0001640455-20-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-20-000006","line_url":"/filing/0001640455-20-000006#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2624.0,"shares_display":"2,624","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":20414.72,"total_display":"20,414.72","total_whole":"20,415","shares_owned_after":44390.0,"shares_owned_after_display":"44,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-10","scope":"insider"},{"id":8595132,"accession":"0001640455-19-000075","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001640455-19-000075","line_url":"/filing/0001640455-19-000075#line-3","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1018.0,"shares_display":"1,018","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":3990.56,"total_display":"3,990.56","total_whole":"3,991","shares_owned_after":47014.0,"shares_owned_after_display":"47,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-16","scope":"insider"},{"id":8595129,"accession":"0001640455-19-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-19-000075","line_url":"/filing/0001640455-19-000075#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2592.0,"total_display":"2,592.00","total_whole":"2,592","shares_owned_after":48032.0,"shares_owned_after_display":"48,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":8595125,"accession":"0001640455-19-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001640455-19-000075","line_url":"/filing/0001640455-19-000075#line-1","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":670.0,"shares_display":"670","price_per_share":4.1,"price_display":"4.10","price_state":"stated","total_value":2747.0,"total_display":"2,747.00","total_whole":"2,747","shares_owned_after":48680.0,"shares_owned_after_display":"48,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":6710989,"accession":"0001640455-18-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-18-000039","line_url":"/filing/0001640455-18-000039#line-2","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5267.0,"shares_display":"5,267","price_per_share":25.01,"price_display":"25.01","price_state":"stated","total_value":131727.67,"total_display":"131,727.67","total_whole":"131,728","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-08","filed_date":"2018-03-12","scope":"insider"},{"id":6404032,"accession":"0001640455-18-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001640455-18-000022","line_url":"/filing/0001640455-18-000022","is_derivative":false,"issuer_cik":"0001340881","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001340881","owner_cik":"0001340881","owner_name":"Drapkin Kimberlee C","owner_display_name":"Drapkin Kimberlee C","owner_url":"/insider/0001340881","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5267.0,"shares_display":"5,267","price_per_share":21.416876779950638,"price_display":"21.42","price_state":"stated","total_value":112802.69,"total_display":"112,802.69","total_whole":"112,803","shares_owned_after":2775.0,"shares_owned_after_display":"2,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Officer (CFO and Treasurer)","n_filings":10,"first_seen":"2018-03-07","last_seen":"2023-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001340881","retrieved_at":"2026-08-24T22:32:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}